The reactivation of the INK4-ARF locus, which is epigenetically repressed by Polycomb proteins in healthy cells, is a hallmark of senescence. One mechanism of reactivating Polycomb-silenced genes is mediated by the epigenetic factor ZRF1, which associates with ubiquitinated histone H2A. We show that cells undergoing senescence following oncogenic Ras expression have increased ZRF1 levels, and that this binds to the p15INK4b, ARF and p16INK4a promoters. Furthermore, ZRF1 depletion in oncogenic Rasexpressing cells restores proliferation by preventing Arf and p16Ink4a expression, consequently bypassing senescence. Thus, ZRF1 regulates the INK4-ARF locus during cellular proliferation and senescence, and alterations in ZRF1 may contribute to tumorigenesis.
INTRODUCTION
The INK4-ARF locus, which encodes the three related genes p15INK4b, ARF and p16INK4a, has a key surveillance function against tumorigenesis.
1,2 The p16INK4a and p15INK4b proteins are cyclin-dependent kinase inhibitors that prevent the CDK4/CDK6-directed phosphorylation of the retinoblastoma protein, and consequently prevent cell cycle progression; in contrast, ARF primarily regulates the activation of the tumor suppressor p53 by negatively regulating MDM2, an E3-ubiquitin ligase of p53. 2 All three products of the INK4-ARF locus are tumor suppressors that act synergistically to generate a protective response against oncogenic insults and other stresses, and they have pivotal roles in activating the senescence response program. [3] [4] [5] Cellular senescence is a stress response induced by a variety of stimuli, including DNA damage, progressive telomere shortening, oxidative stress and activated oncogenes. 5, 6 After induction, senescent cells halt proliferation and express critical mediators of tumor suppression, including p15INK4b, p16INK4a and ARF. 3 Thus, senescence is a potent tumor suppressor mechanism in premalignant lesions that must be overcome to allow progression to full-blown malignancy. 7 Mediators of the senescence response, not all of which have been characterized, are also likely to have roles in tumor suppression.
Chromatin regulation has been strongly implicated in engaging the cellular senescence program, although many details remain unknown. Among the best identified changes are epigenetic alterations in the INK4-ARF locus. 8, 9 The Polycomb group proteins (PcG) and the Trithorax group proteins (TrxG) have recently emerged as important regulators of INK4-ARF expression in cellular senescence, with opposing roles: while TrxG proteins facilitate locus activation, PcG proteins within the polycomb repressive complex (PRC)1 and PRC2 complexes maintain locus repression under normal proliferative conditions. 10, 11 During senescence, the H3K27 trimethyl (H3K27me3) repressive mark is lost, and PRC1 is displaced from the INK4-ARF locus, though the exact molecular mechanisms that regulate this change remain unknown.
Furthermore, the loss of certain PcG members can induce premature senescence, due in part to derepression of the INK4-ARF locus. [12] [13] [14] On the other hand, following senescence stimuli, the TrxG protein MLL1 and the histone demethylase JMJD3 are recruited to the INK4-ARF locus, where they facilitate derepression of the locus by depositing H3K4me3 activation marks and removing H3K27me3 repressive marks, respectively. [15] [16] [17] This further highlights the complexity of the epigenetic regulation of this locus. Epigenetic deregulation of the INK4-ARF locus is also known to have a major impact on tumorigenesis. 1 Silencing of the p16INK4a and p15INK4b genes by promoter hypermethylation is a highly frequent and early event in numerous types of human cancer, including squamous cell carcinoma, leukemia and myelodysplasia. 18 Previous reports have shown that mice deficient for all three open reading frames of the INK4-ARF locus are highly tumor prone and develop predominantly skin tumors and soft-tissue sarcomas.
during retinoic acid (RA)-induced neuronal differentiation of the NT2/D1 cell line. 19 This promotes the transcriptional activation of Polycomb target genes during differentiation. 19, 21 Previous publications indicated that gene expression from the INK4-ARF locus is induced in differentiating NT2/D1 cells. 22, 23 Gene expression profile analyses in NT2/D1 cells have shown p15INK4b to be a putative target gene regulated by ZRF1. 19 Interestingly, Polycomb complexes in NT2/D1 cells control the INK4-ARF locus, as chromatin immunoprecipitation (ChIP)-on-chip analysis indicated that the locus is a RING1B and H2AK119ub-target. 19 Therefore, we asked whether ZRF1 could be directly implicated in regulating the locus in NT2/D1 cells. To address this, we generated stable NT2/D1 control and ZRF1-depleted cell lines and treated them with RA to induce differentiation. RA treatment did not alter the expression of ZRF1 at either the mRNA or the protein level during the time points studied (Figure 1b and Supplementary Figure S1a) . However, the RA-induced expression of p15INK4b, ARF and p16INK4a was compromised in ZRF1-depleted cells (Figure 1a ). To strengthen our observation, we performed western blot analysis from total protein extracts in both control and ZRF1-knockdown cells. Importantly, p15INK4b, ARF and p16INK4a protein levels were also compromised upon ZRF1 depletion ( Figure 1b) . As a control, we also analyzed known RA-responsive genes in both control and ZRF1-depleted NT2 cells (Supplementary Figure S1b) . 19, 24 Expression of non-ZRF1 target genes, such as MEIS2 and OAT, was not affected in ZRF1-depleted cells. On the other hand, the expression of ZRF1 target genes HOXA4 and HOXA5 was reduced (Supplementary Figure S1c) . We next asked whether ZRF1 might directly regulate the derepression of the INK4-ARF locus upon RA stimulus. Treating NT2/D1 cells with RA led to ZRF1 recruitment to the p15INK4b, ARF and p16INK4a promoters (Figures 1c and d) . We additionally observed RING1B and SUZ12 displacement, with a consequent loss of H3K27me3, from the ARF and p16INK4a promoters (Figures  1c and d) . These results indicate that, following RA treatment, ZRF1 directly regulates the expression of the INK4A-ARF locus by facilitating the displacement of PRC1.
ZRF1/MIDA1 expression is induced by oncogenic H-Ras The INK4-ARF locus has been described as a key regulator of both replicative senescence and oncogene/stress-induced senescence. 25, 26 Therefore, our observation that ZRF1 directly regulates the INK4-ARF locus in NT2/D1 prompted us to hypothesize that ZRF1 has a potential role not only in differentiation but also during senescence. Polycomb complexes bind and regulate the INK4-ARF locus in proliferating human and mouse fibroblasts. 13 During oncogene-induced senescence (OIS), both Polycomb proteins and the repressive H3K27me3 mark must be removed from this locus in order to reactivate its transcription. We investigated the role of ZRF1 in activating the INK4-ARF locus during OIS, using mouse embryonic fibroblasts (MEFs) that express oncogenic H-Ras (hereafter referred to as Ras). 25 As early as 2 days after puromycin selection (that is, Ras expression), the mRNA transcripts of p15Ink4b, Arf and p16Ink4a were upregulated, as previously described (Figure 2a) . 25, 27 Strikingly, the mouse ortholog of ZRF1, MIDA1, which shares 93% identity with ZRF1, 28 was upregulated at both the mRNA and protein levels upon Ras expression (Figures 2b and c) , coinciding with an accumulation of p53 and p16Ink4a (Figure 2c) . Interestingly, the increased MIDA1 expression remained constant over time in senescent cells (Supplementary Figure 1d) . Furthermore, as ZRF1 is known to localize to both the cytoplasm and the nuclei of mammalian cells, 19 we performed subcellular fractionation of MEFs expressing Ras. This revealed an accumulation of MIDA1 mainly in the nuclear fraction (Figure 2d ), suggesting a role for MIDA1 predominantly in gene regulation during OIS.
To investigate whether the mechanism of ZRF1 in regulating the INK4-ARF locus in senescent cells is conserved between human and mouse, we next expressed Ras in primary human fibroblasts (IMR90). Indeed, we also observed an increase in ZRF1 upon Ras expression in IMR90 cells ( Figure 2e ) concomitant with an upregulation of the p15INK4b and p16INK4a transcripts ( Figure 2f ). As previously reported for IMR90 cells, we did not detect an upregulation of the ARF transcript 29 ( Figure 2f ). Furthermore, ZRF1 upregulation was also detected by western blot in IMR90 transduced cells with Ras ( Figure 2g ). We also observed a decrease in the mRNA and protein levels of the PRC2-subunit EZH2 (Supplementary Figure 1e) , as previously described.
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ZRF1/MIDA1 is recruited to the INK4-ARF locus during H-Ras-induced OIS We next asked whether MIDA1 directly regulates the mouse Ink4-Arf locus via a Polycomb-dependent mechanism. To elucidate whether MIDA1 is recruited to the Ink4-Arf locus during its reactivation upon OIS, we performed ChIP experiments using an anti-ZRF1 antibody in MEFs infected with either a control vector or one that expresses Ras. We found that MIDA1 was consistently recruited to the locus following Ras overexpression, and that this correlated with a decreased binding of Ring1B and reduced H3K27me3 levels ( Figure 3a) . Interestingly, the most pronounced changes regarding the recruitment of MIDA1 occurred at the promoter region of p15INK4b and around the promoter and first exons of Arf and p16Ink4a ( Figure 3a ). Oncogenic Ras expression is also followed by RING1B displacement and by the reduction of the repressive mark H3K27me3 from Arf and p16Ink4a ( Figure 3a) . Additionally, ChIP analysis of ZRF1 in Ras-expressing IMR90 human cells indicated that ZRF1 was also recruited to the promoter and first exon regions of p15INK4b and p16INK4a (Figure 3b ), while changes in RING1B, SUZ12 and H3K27me3 levels were observed only at p16INK4a, suggesting a more complex regulatory mechanism of this locus in human as compared with mouse cells (Figure 3b ). Together, these results indicate that ZRF1/MIDA1 directly binds the INK4-ARF during oncogene-induced stress.
Ectopic expression of ZRF1/MIDA1 leads to activation of the p16INK4a and inhibits proliferation To investigate whether ZRF1 has a functional role in regulating the INK4-ARF locus, we ectopically expressed either wild-type ZRF1 or a ZRF1 mutant (ZRF1DUBD), which cannot bind to H2AK119ub, 19 in IMR90 cells. We analyzed whether ectopically expressed ZRF1 was sufficient to induce derepression of the INK4-ARF locus, and whether it required H2AK119ub. Overexpression of wild-type ZRF1 led to a significant upregulation of the p15INK4b and p16INK4a transcripts but not of ARF (Figure 4a ). Conversely, expression of ZRF1DUBD was not sufficient to derepress p16INK4a, while p15INK4b expression was significantly lower when compared with wild-type ZRF1 (Figure 4a ). We next investigated whether upregulation of p15INK4b and p16INK4a upon ZRF1 overexpression was sufficient to induce a senescence-like arrest. Interestingly, ectopic expression of wild-type ZRF1 led to a significant proliferation defect of IMR90 cells, as determined by reduced Bromodeoxyuridine (BrdU) incorporation (Figure 4b ) and an increased activity of senescence-associated b-galactosidase (Figure 4c ). However, in agreement with the gene expression data, we observed that overexpression of ZRF1DUBD led to partial induction of senescence, as compared with wild-type ZRF1 (Figures 4b and c) , which could be explained though the incomplete derepression of p15INK4B, which was previously reported to trigger senescence when ectopically expressed in human fibroblasts. 30 In proliferating IMR90 cells, RING1B is not detected by ChIP analysis at p15INK4B regulatory regions. Nevertheless, ZRF1 is necessary to activate p15INK4B expression, apparently in a H2AK119ub-independent manner. Strikingly, MEFs overexpressing wild-type ZRF1 also upregulated p16INK4a expression (Figure 4d ), which was mirrored by increased senescence-associated b-galactosidase positive cells (Figure 4e ). These findings indicated that ZRF1/MIDA1 is necessary to activate p16INK4A, both in human and mouse fibroblasts. Depletion of ZRF1/MIDA1 cooperates with oncogenic H-Ras for bypassing senescence From the data presented above, we conclude that ZRF1/MIDA1 contributes to the activation of the INK4-ARF locus. Expression of oncogenic Ras triggers senescence, which depends on the functional activity of the INK4-ARF locus, while impaired expression of this locus can lead to a bypass of Ras-induced senescence and may facilitate tumor development. To functionally test whether a lack of ZRF1/MIDA1 would prevent OIS, we generated control and MIDA1-depleted MEFs with or without Ras overexpression. In both cases, the MIDA1 knockdown was efficient, as shown by quantitative real time PCR (qRT-PCR) from total RNA (Figure 5a ). Interestingly, depletion of MIDA1 in Rasexpressing cells reduced the induction of p16Ink4a, and led to a slight reduction in the levels of Arf transcript and protein (Figures  5b and c) . At the functional level, MIDA-depleted, Ras-expressing MEFs continued to proliferate, and formed colonies when plated at low density (Figure 5d ). We next tested this functional role for ZRF1/MIDA1 in another cell type, namely, primary mouse keratinocytes, and observed that also in these epithelial cells, knockdown of MIDA1 efficiently inhibited OIS induction (data not shown). This indicated that ZRF1/MIDA1 is required to stably activate the Ink4a-Arf locus during the induction of senescence.
Next, using human primary keratinocytes as a well-established model to study senescence bypass, 31 we investigated whether ZRF1 is implicated in regulating senescence in human cells. Oncogenic mutations in H-Ras, as well as INK4a-ARF missregulation, are frequent in skin lesions and contribute to the onset of squamous cell carcinoma. 32 Importantly, we also observed a proliferative advantage in human keratinocytes depleted for ZRF1 and OIS bypass in keratinocytes when these were co-infected with Ras and a short hairpin RNA (shRNA) against ZRF1 (Figure 6a ). Senescence evasion in human keratinocytes developed with reduced p16INK4a levels (Figure 6b) , corroborating a role for ZRF1 as an activator of p16INK4A in human keratinocytes.
These results further reinforce the hypothesis that ZRF1/MIDA1 associates with the INK4A-ARF locus upon OIS in primary cells and antagonizes PRC1-mediated silencing at the locus (Figure 6c ).
DISCUSSION
Regulation of the INK4-ARF locus is a complex and highly controlled process that is central to normal physiology and tumor suppression. As such, understanding how these genes are regulated is critical. We focused our study on ZRF1/MIDA1, a recently characterized epigenetic factor that is specifically recruited to chromatin that is decorated with mono-ubiquitinated histone H2A, and which thus competes with RING1B at the onset of differentiation.
Here, we present evidence that ZRF1/MIDA1 regulates the activation of the INK4-ARF locus not only during the differentiation process but also upon OIS. We demonstrate that ZRF1/MIDA1 is upregulated by OIS. However, it remains to be elucidated whether the activation of the INK4A-ARF locus by ZRF1 is solely dependent on the displacement of PRC1 from chromatin, or whether other additional mechanisms are required. We propose that ZRF1 facilitates transcription at the INK4A-ARF locus by recruiting specific deubiquitinases to chromatin, as previous in vitro experiments have suggested. 19 In addition, ZRF1 might cooperate with or facilitate the activity of JMJD3 and MLL1, both of which are necessary for INK4-ARF activation, [15] [16] [17] through its stabilization at chromatin.
Interestingly, ZRF1 recruitment to p15INK4b in the NT2/D1 cell line and fibroblasts apparently is independent of H2AK119ub. We speculate that specific transcription factors could recruit ZRF1 to p15INK4b during differentiation or OIS.
Distinct post-translation modifications are likely to be essential for regulating the levels of epigenetic modifiers at the INK4-ARF locus in proliferating and senescent cells. For instance, the ubiquitin-specific proteases USP7 and USP11 regulate ubiquitination of the posterior sex combs (PSC) and sex combs extra (Sce) Polycomb proteins; this consequently controls the levels of PRC1 at the INK4-ARF locus. 33 As ZRF1 is subject to phosphorylation during mitosis or following RA stimulation, 34, 35 it will be interesting to determine in the future whether post-translational modifications of ZRF1 affect its recruitment to the INK4-ARF locus, or its ability to displace PRC1 and PRC2 from the locus.
Our study raises the possibility that ZRF1 is implicated in aging, as p16INK4a upregulation and other senescence features are associated with aging. Intriguingly, a previous study has identified ZRF1/MIDA1 as part of the aging signature of the skin of aged mice. 36 Both senescence and aging correlate with loss of the regenerative capacity of certain adult stem cells. Understanding how the epigenetic role of ZRF1 in activating the INK4-ARF locus is associated with the aging of adult stem cells will be a focus of future research.
We demonstrate that depletion of MIDA1 in MEFs and primary keratinocytes that express oncogenic H-Ras impairs the activation of p16Ink4a and Arf, contributing to senescence bypass. Cellular senescence is a block to tumor progression and an early event in tumorigenesis. 7 Interestingly, analysis of the Oncomine database (www.oncomine.org) points to a reduced expression of ZRF1 in breast cancer and chronic lymphocytic leukemia. Loss of heterozygosity at ZRF1 has been reported in several cancer cell lines, according to the CONAN (copy number analysis) database (http://www.sanger.ac.uk/cgi-bin/genetics/CGP/conan/search.cgi). In contrast, other studies have suggested that ZRF1 might have an oncogenic role in head and neck squamous cancer (HNSCC). 37 However, most of these studies are more descriptive in nature and were performed on established cell lines in which important pathways in cellular senescence and tumorigenesis are abrogated. Based on our observations, functional studies are needed to address whether increased levels of ZRF1 are linked to benign and pre-malignant lesions in tissues in which senescence occurs, and whether progression towards malignancy is associated with a loss of ZRF1. Overall, our data support a possible role of ZRF1 as a tumor suppressor that is critical for establishing a response to OIS, and suggests that derailing this response might be involved in tumorigenesis.
MATERIALS AND METHODS

Antibodies used for ChIP and western blot analysis
The following antibodies were used: anti-tubulin (Abcam 7291, Abcam, Cambridge, UK), anti-p15 (Santa Cruz k-18, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), anti-p16 (Santa Cruz C-20 and M-156), anti-RING1B 
Cell culture, transfections and viral infections
MEFs were prepared from embryonic day 13.5 embryos of the C57BL/6 inbred strain. MEFs, IMR90, NTERA (NT2-D1), HEK293T and Phoenix Ecotropic/Ampho were cultured with Dulbecco's modified Eagle's medium (Gibco/Invitrogen, Life Technologies Ltd., Paisley, UK) supplemented with 10% fetal bovine serum at 37 1C with 5% CO 2 .
In all, 2 Â 10 6 HEK293T cells were transfected with 7 mg of pLKO (mammalian expression lentiviral RNAi vector pLKO)-shRNA (Sigma-Aldrich, St Louis, MO, USA), 5 mg of pCMV-VSV-G (envelope vector for pseudotyping of Moloney Murine Leukemia virus (MMLV)-based retroviral vectors), and 6 mg of pCMVDR-8.91 plasmids to produce lentivirus containing LKOshRNA. After 72 h, NT2/D1 cells were infected overnight with the viruscontaining media filtered with 5 mg per ml of polybrene (Sigma). Cells were selected 24 h after infection with 2.5 mg per ml of puromycin (Sigma) for 2 days. The pLKO sequence is shown in Supplementary Table S1  (Supplementary Table S1 ).
Phoenix Ecotropic/Ampho packaging cell line cells were transfected with the retroviral vectors pBabe-H-RAS G12V , pMSCV (murine stem cell virus vector) Empty, pMSCV-ZRF1, pMSCV-ZRF1DUBD or pRETROSUPER (NKI-AVL, Amsterdam, Netherlands) containing the shRNA against MIDA1 (Supplementary Table S1 ), pp16Ink4a and p53 38 to produce retrovirus containing pRS (mammalian expression retroviral RNAi pRETROSUPER vector)-shRNA. Virus-containing media was collected 48 h after transfection, and MEFs were infected with 5 mg/ml polybrene. Cells were selected 24 h after infection with 2.5 mg per ml of puromycin (Sigma) and 100 mg per ml of hygromycin (Sigma).
Primary human keratinocytes were isolated from adult foreskin and cultured together with a feeder layer of fibroblasts (J2-3T3) as described previously. 39 Keratinocytes were infected with pRETROSUPER containing the shRNA against ZRF1 (Supplementary Table S1 ), using PhoenixA cells. Keratinocytes were selected for 2 days with 2 mg/ml puromycin and 100 mg/ml hygromycin. Infected keratinocytes were grown for 5 days after the cycle of infection, selection and reseeding for experimentation.
Plasmids and Cloning
Full-length ZRF1 and DUBD mutant were subcloned from pCMV2ZRF1 and pCMV2ZRF1DUBD 19 into the pMSCV vector by digestion with the BamHI and XhoI restriction enzymes (Fermentas GmbH, St Leon-Rot, Germany) and used to produce stable cell lines by retroviral infection of MEF and IMR90 cells.
qRT-PCR analysis RNA was extracted with the RNA extraction kit (Qiagen, Hilden, Germany). complementary DNA (cDNA) was generated from 0.5 mg of RNA with the First Strand cDNA Synthesis Kit (Fermentas). cDNA was diluted to 100 ml with water, and 2 ml samples were used for each RT-qPCR reaction, using SYBR green (Roche, Basel, Switzerland). The primers used in the RT-qPCR assays are listed in Supplementary Table S1 .
ChIP assays NT2/D1, MEFs and IMR90 cells were trypsinized and crosslinked in 1% formaldehyde for 10 min at room temperature. Crosslinking was quenched with a 0.125 M glycine solution for 5 min in formaldehyde, and cells were washed twice with 1 Â PBS. Pelleted cells were lysed in 1 ml ChIP buffer (1 volume of sodium dodecyl sulfur buffer with 0.5 volumes of Triton buffer), and sonicated for 8 min in a Bioruptor (Diagenode, Liè ge, Belgium). Soluble material was quantified by Bradford assays. ZRF1 was immunoprecipitated from 1000 mg of protein and RING1B from 500 mg, and 100 mg of immunoprecipitated histone/histone modifications were used. Antibodies were incubated overnight with the chromatin in a 500 ml volume. Immunocomplexes were recovered with 30 ml of a protein A bead slurry. Immunoprecipitated material was washed three times with a low-salt buffer and once with a high-salt buffer. DNA complexes were decrosslinked in 100 ml decrosslink buffer (1% sodium dodecyl sulfur and 100 mM NaHCO 3 ) at 65 1C for 3 h, and DNA was then eluted in 100 ml of water (Braun wate, Braun Medical S.L, Barcelona, Spain) using a PCR purification kit (Qiagen). DNA (2 ml) was used for each qPCR reaction with SYBR green (Roche). The primers and antibodies used are given in Supplementary Table S1 .
BrdU incorporation assay IMR90 cells were treated with 10 mM of BrdU solution for 1 h and then analyzed for BrdU incorporation by flow cytometry, using the APC BrdU Flow Kit (BD Pharmigen, Franklin Lakes, NJ, USA) according to the manufacture's protocol.
Senescence-associated-b-galactosidase assay IMR90 and MEFs were fixed with 0.5% glutaraldehyde (Sigma) in PBS and stained for senescence-associated b-galactosidase activity as previously described. 40 Pictures were acquired using a Leica CTR6000 microscope (Leica Microsystems Wetzlar GmbH, Wetzlar, Germany) at the total magnification of Â 100.
Western blot analysis and nuclear fractionation Cell extracts for western blot analysis were prepared in lysis buffer (50 mM Hepes, pH 7.5, 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid (EDTA), 2.5 mM ethylene glycol tetraacetic acid (EGTA), 0.1% Tween 20 and proteinase inhibitors), sonicated 15 s in a Brason Sonifier (Branson Ultrasonics, Danbury, CT, USA), and centrifugated 20 min at maximum speed at 4 1C. Protein suppernatant was diluted in 4 Â Laemmli buffer and analyzed with sodium dodecyl sulfur-polyacrylamide gel electrophoresis.
Nuclear extracts for western blots were prepared in hypotonic buffer (5 mM PIPES (piperazine-N,N 0 -bis(2-ethanesulfonic acid) buffering agent) pH 8, 85 mM KCL, 0.5% NP-40 and proteinase inhibitors), kept on ice for 10 min, and centrifugated 5 min at 5000 g. Supernatants were collected 
Colony formation assay
MEFs were plated at 2500, 5000 or 10 000 cells per well in duplicate during 10 days. Cells were fed every 2 days for 10 days. After 10 days, cells were washed with 1 Â PBS, fixed with 4% formalin (Sigma) for 15 min, rinsed with 1 Â PBS, and stained with crystal violet solution (1% in 1 Â PBS) for 20 min. Cells were then washed 4 Â with H 2 O and allowed to air dry.
